Evidence map›Paper›PMID 31792275›Full record

ArticleScientific data2019

Benefits and barriers in the design of harmonized access agreements for international data sharing.

Katie M Saulnier, David Bujold, Stephanie O M Dyke, Charles Dupras, Stephan Beck, Guillaume Bourque, Yann Joly

Abstract read
In one paragraph

Article in Scientific data, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. EpiATLAS - a reference for human epigenomic research.bioRxiv : the preprint server for biology · 2026
    Article
  4. Toward ethical provenance tracking: The GA4GH model data access agreement (DAA).Genetics in medicine : official journal of the American College of Medical Genetics · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Katie M SaulnierCentre of Genomics and Policy, McGill University, Montreal, Canada. katie.saulnier@mcgill.ca.ORCID http://orcid.org/0000-0002-0721-6280
David BujoldMcGill University and Genome Quebec Innovation Centre, Montreal, Canada.ORCID http://orcid.org/0000-0001-7860-3264
Stephanie O M DykeCentre of Genomics and Policy, McGill University, Montreal, Canada.
Charles DuprasCentre of Genomics and Policy, McGill University, Montreal, Canada.ORCID http://orcid.org/0000-0002-9194-3252
Stephan BeckUniversity College London, London, United Kingdom.ORCID http://orcid.org/0000-0001-5290-2151
Guillaume BourqueMcGill University and Genome Quebec Innovation Centre, Montreal, Canada.ORCID http://orcid.org/0000-0002-3933-9656
Yann JolyCentre of Genomics and Policy, McGill University, Montreal, Canada.ORCID http://orcid.org/0000-0002-8775-2322

Funding

DH | National Institute for Health Research (NIHR) BRC369/CN/SB/101310
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31792275
PMCPMC6889499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.